Rosty Raykov - 08 Oct 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Rosty Raykov
Issuer symbol
FENC
Transactions as of
08 Oct 2025
Net transactions value
$0
Form type
4
Filing time
08 Oct 2025, 17:08:28 UTC
Previous filing
06 Oct 2025
Next filing
03 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Raykov Rosty Director C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK /s/ Rosty Raykov 08 Oct 2025 0001468316

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $11,292 +4,609 +5.6% $2.45 87,110 08 Oct 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise $11,292 -4,609 -0.28% $2.45 1,634,184 08 Oct 2025 options 4,609 $2.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.